The ASPC Congress on CVD Prevention is taking place in Arlington, Texas, July 21-23. Here, G.B. John Mancini, MD, University of British Columbia, emphasizes the importance of having an international perspective on preventive cardiology.
Cardiovascular disease is one of the most common and costly health care problems worldwide, and preventive cardiology can be discussed as secondary, primary, or primordial. There is tremendous opportunity to work multilaterally, emphasized G.B. John Mancini, MD, professor of medicine; scientific director, Cardio Risk Clinic; and director of the Cardiovascular Imaging Research Core Laboratory, University of British Columbia.
On Day 1 of the American Society for Preventive Cardiology’s Congress on CVD Prevention, in the session, “What Is Preventive Cardiology,” Mancini presented, “The Canadian Perspective.”
Transcript
What is preventive cardiology, and why it is important to have an international perspective on this disease?
Cardiovascular disease is one of the most common and costly health care problems worldwide, and so preventive cardiology is generally discussed as secondary or primary or primordial. For example, secondary prevention would be, if someone has had a heart attack, you never want them to have another one—so you would treat accordingly all the risk factors. Primary prevention is someone who you don't want to have a heart attack, but you know they have risk factors—they may have high blood pressure or they smoke—and so you want to deal with those things. Primordial prevention is avoiding the risk factors altogether—we don't want our kids to become obese or to develop diabetes or to start smoking, etc.
So this conference, one of the themes is what is exactly preventive cardiology and who should be doing it. I think that there's tremendous opportunity to work multilaterally. We have representation here from Europe; from Canada, through myself; and the US, talking about the training challenges, the clinical challenges of what is currently a multidisciplinary system, but which of course requires core competencies—whether this person is a cardiologist or an endocrinologist or what have you—and what those core competencies should be and how they should be delivered. Training programs is an area that I think is fruitful to pursue as a result of this conference.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Dr Yehuda Handelsman: DCRM Guidelines Are Shaping Integrated, Global CRM Care
January 3rd 2025In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty practice recommendations and the updated DCRM 2.0 guidelines.
Read More